Purchase Order SPE2DP25P0305

Award Date 4/11/25
Potential Completion Date 4/28/25
Potential Value $3.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DP25P0215, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment located in Lake Zurich, Illinois. The $1,101.28 firm fixed-price purchase order is for the supply of blood packs with anticoagulant, a critical medical consumable that supports healthcare and biomedical research programs, including military medical supply chains. Fenwal, Inc. is a registered federal vendor that has...
This $1,839.04 firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of 8510030904 - BLOOD PACK WITH ANT, a medical supply item used in transfusion medicine and cell therapy applications. Fenwal, a registered government vendor since 2007, has a history of providing a diverse array of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company based in Lake Zurich, Illinois. The contract, valued at $2,937.60, is for the supply of Blood Pack with Anticoagulant (BLOOD PACK WITH ANT). This is a firm fixed-price purchase order contract without any set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007. The company has a...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of blood pack units with anticoagulant, with a ceiling value of $1,101.28 and a completion date of June 30, 2025. Fenwal, Inc. is a global blood technology company and a registered vendor with the U.S. federal government, providing specialized medical equipment and consumables to support...
This federal contract award, with ID SPE2DP25P0334, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $15,417.92 firm fixed-price purchase order is for the supply of blood packs with anticoagulant. This contract does not have a set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government and has a history of securing contracts with various...
This federal contract award, valued at $1,839.04, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of blood packs with anticoagulant (8510030842) and has a completion date of August 14, 2023. Fenwal, a registered federal vendor since 2007, has a strong track record of supporting the U.S. government's healthcare and research initiatives by providing a diverse array...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical devices and supplies. The contract, valued at $1,871.34, is for the delivery of hand-operated blood pack sealers. This award supports critical healthcare programs, including military medical supply chains, biomedical research initiatives, and blood banking operations. Fenwal, Inc. is a registered vendor with the U.S. federal government and...
This is a $16,608.88 firm fixed-price purchase order contract awarded by the Defense Health Agency to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment and supplies. The contract is for the provision of intravenous fluids for use in the agency's blood bank operations. This award does not have a set-aside designation, reflecting Fenwal's specialized expertise in transfusion medicine and cell therapy technologies. Fenwal has a history of providing critical medical...
This is a $21,400 firm-fixed-price purchase order awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, by the Defense Health Agency. The contract is for the supply of various medical supplies and equipment to support transfusion medicine and cell therapy applications, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The award does not have a set-aside...
This federal contract award, valued at $2,202.56, was issued by the Defense Logistics Agency's Medical Supply Chain division to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the procurement of blood packs with anticoagulant, classified under the product code 8511121932. This is a firm fixed-price purchase order with a period of performance ending on March 17, 2025. The award does not have a set-aside designation, reflecting Fenwal's...

This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of blood collection and transfusion products. The $3,303.84 contract is for the delivery of blood packs with anticoagulant, which support healthcare and biomedical research initiatives. Fenwal has established itself as a key supplier to various federal agencies, including the Department of Veterans Affairs, National Institutes of Health, and Defense Health Agency, providing a wide range of specialized medical technologies and preventative maintenance services. This particular contract does not have a set-aside designation, reflecting Fenwal's unique capabilities in the field of transfusion medicine and cell therapy.

Generated 7/11/25, 9:52 AM